CVNA — Carvana Co.

The tape and the fundamentals are pulling in opposite directions as of 2026-10-04. Operating news has been unambiguously good - 10 consecutive quarters of growth and profitability, 197,325 retail units (+38% YoY) in Q2 2026, revenue +52% YoY, and raised EBITDA guidance - yet the shares fell 14.0% in the prior month and sit 11.4% below the 200-day SMA. That is multiple compression, not estimate cuts. Analyst positioning is genuinely split rather than the 'predominantly bullish' picture in the briefing: the FMP data shows 21 Buy, 22 Hold, 2 Sell and 1 Strong Sell (consensus 'Hold') against an $85.23 average target, while the brief cites 28-33 buys and zero sells. The market is treating CVNA as a high-beta (3.5) source of funds in a growth-cooling tape and demanding proof that unit margins hold while volume grows.

The three-year revenue trend is a genuine inflection, not a blip: quarterly revenue ran $2.77B (Q3 2023) to $2.42B (Q4 2023), then $3.06B, $3.41B, $3.66B, $3.55B through 2024, then $4.23B, $4.84B, $5.65B, $5.60B through 2025, and $6.43B and $7.38B in H1 2026. YoY growth accelerated from +24.4% (Q1 2025) to +30.1% (Q2 2025) to +54.5% (Q3 2025) to +58.0% (Q4 2025), and has now plateaued at ~+52% for two straight quarters (Q1 2026 $6.432B vs $4.232B; Q2 2026 $7.376B vs $4.840B). That is deceleration off a peak but still extraordinary absolute growth. The problem is underneath the top line: gross margin has compressed from 21.2% in Q2 2025 to 20.3% in Q3 2025, 18.8% in Q4 2025, 19.8% in Q1 2026 and 18.8% in Q2 2026 - roughly 240bps of YoY erosion. Operating margin followed: 10.6% in Q2 2025 versus 9.2% in Q2 2026 (-140bps YoY), though still well above Q2 2024's 7.6%. In dollar terms this is still progress - operating income rose from $513M to $680M YoY and $394M to $581M sequentially. Reported net income is noisy and should not be trended naively: Q3 2023 ($782M) and Q4 2025 ($857M, $1.192 diluted EPS) both carry obvious one-offs, which is why TTM EPS of $2.185 sits above the analyst next-FY estimate of $1.616. Free cash flow is the cleanest signal and it is consistently positive - nine of the last ten quarters, including $187M in Q2 2026, $379M in Q4 2025 and $307M in Q3 2025, with only Q2 2025 negative at -$2M. Verdict: volume growth structural and still accelerating on a multi-year view; per-unit profitability is being traded away to get it.

Not cheap, and the headline multiple is misleading. As of 2026-10-04 at $63.78, the reported P/E TTM of 22.0x flatters the stock - that TTM window includes the one-off $1.192 diluted EPS quarter in Q4 2025, and even the supplied TTM EPS of $2.185 implies ~29x, not 22x. On the analyst next-FY EPS of $1.616, the forward P/E is ~39.5x. PEG TTM of 0.092 is effectively meaningless given the one-off distortion. P/S of 2.79x is more than double the 5-year average of 1.35x, P/B is 11.4x, and EV (~$72.2B using $69.96B market cap + $4.854B long-term debt - $2.63B cash) is ~25x the midpoint of 2026 Adjusted EBITDA guidance ($2.85B). The stock is genuinely cheaper than its 5-year average P/E of 57.5x, but that average was set during a loss-making, cash-burning era that no longer exists - it is not a valid anchor. My read: fair-to-fully valued, with the entire case resting on EBITDA compounding 25%+ and gross margin finding a floor.

This is a pure multiple-compression story as of 2026-10-04. The stock has fallen from a 52-week high of $97.38 to $63.78 (-34%) while revenue guidance went the other way - and the forward EPS estimate of $1.616 is deliberately below trailing EPS of $2.185 because 2025's Q4 carried a one-off. So the market is paying ~39x for forward earnings that look depressed only by comparison, while the underlying EBITDA run-rate is compounding. The practical read: the market has stopped paying for growth at any price and is now underwriting unit economics. Watch Q3 2026 (due 2026-10-28) for two numbers that matter more than the revenue line - retail GPU and gross margin. If units keep growing >30% YoY and gross margin stabilizes at 19-20%, the multiple has room to re-rate toward the $85 consensus target. If gross margin prints another leg down toward 17-18%, the stock can keep falling on good revenue, exactly as it has this quarter. Do not buy this name on the revenue beat alone.

As of 2026-10-04, the technical setup is weak but not washed out. RSI(14) stood at 43.11 - below neutral, above oversold, so there is no capitulation signal to buy into. Price was 4.5% below the 20-day SMA (implied ~$66.8), 7.24% below the 50-day SMA (implied ~$68.8) and 11.37% below the 200-day SMA (implied ~$72.0) - a clean, ordered downtrend with all three averages stacked above the price. Returns: -1.98% over one week, -14.01% over one month, -7.04% over three months, but +1.58% over six months, which means the decline is recent and the six-month base is roughly flat. Price sits in the lower half of the $54.46-$97.38 52-week range. Entry-timing implication: there is no technical confirmation of a bottom. The first meaningful signal would be a reclaim of the 50-day SMA near $68.8, which would also represent roughly 8% upside from here. With a beta of 3.5, anyone entering before that signal is accepting a wide drawdown path - the 52-week low of $54.46 is 15% below the current price.

• Interest rates and consumer auto-loan affordability: Carvana is directly levered to the cost of vehicle financing. Its ability to tap the ABS market - including its first mixed-inventory (new-plus-used) deal - has insulated it from the worst funding stress, but higher-for-longer rates still pressure the near-prime and subprime buyers that make up a large slice of used-vehicle demand.
• Used-vehicle pricing and depreciation: Falling wholesale values compress GPU on inventory held on the balance sheet and reduce the realizable value of reconditioned units. Wholesale auction revenue via ADESA is also directly exposed to used-price direction.
• New-vehicle affordability and tariffs: Sustained high new-car prices push consumers into the used market, a structural tailwind for volume - but tariffs on parts and imported components raise reconditioning and repair costs, which is one plausible driver of the gross-margin compression visible in the data.
• Rotation away from high-beta growth: With a beta of 3.5 (FMP) and a 3.5x-plus sensitivity to risk appetite, CVNA is a first-funding source in risk-off rotations, which is a large part of why it de-rated 34% from its high while the business accelerated.
• Competitive intensity in used auto: CarMax, franchised-dealer CPO programs and other digital entrants are all chasing the same inventory. Carvana's superior GPU versus franchise dealers gives it pricing flexibility, but the 240bps of gross-margin erosion over four quarters suggests it is actively spending that advantage to take share.

• Q3 2026 earnings on 2026-10-28 - the single most important data point. Confirmation of >30% retail unit growth with stabilizing GPU/gross margin validates the bull case; another margin leg down validates the de-rating.
• Progress against the raised full-year 2026 Adjusted EBITDA guidance of $2.7-3.0B, including any further upward revision at Q3 or Q4.
• Ramp of ADESA reconditioning capacity and cost-per-unit improvements without greenfield capital spend - the core of the margin-recovery argument.
• Continued ABS market access and any decline in benchmark rates, which would lower Carvana's funding costs and improve both consumer monthly payments and company-level interest expense.
• Analyst target revisions: consensus sits at $85.23 (high $120, low $67) against a $63.78 price as of 2026-10-04, so a post-Q3 round of upgrades is a plausible re-rating trigger.

• Gross-margin compression is the central risk and it is already visible: 21.2% in Q2 2025 to 18.8% in Q2 2026, with operating margin down 140bps YoY over the same span. If growth is being bought with price, EBITDA guidance of $2.7-3.0B becomes hard to defend.
• Leverage and financing sensitivity: $4.854B of long-term debt against $2.63B of cash and $4.028B of stockholders' equity as of 2026-06-30, with debt-to-equity of 1.395. Carvana's model depends on continuous ABS and warehouse funding access; a credit-market shutout would be severe.
• Valuation leaves no room for error: 2.79x P/S versus a 5-year average of 1.35x, ~25x EV/EBITDA on 2026 guidance, and ~39.5x the analyst next-FY EPS of $1.616. A ~34% drawdown from the high has not made this a value stock.
• Earnings quality and comparability: one-off items produced $782M of net income in Q3 2023 and $857M in Q4 2025, making TTM figures, P/E, PEG and any trend screen unreliable. This cuts both ways - it can flatter a 'cheap' P/E and it masks the true normalized earnings power.
• Extreme volatility and drawdown risk: beta of 3.497 and a 52-week range of $54.46-$97.38 mean a 15%+ move to the 52-week low is entirely plausible on a single disappointing print or a macro risk-off week.
• Regulatory and consumer-credit scrutiny: as a large originator and servicer of near-prime auto loans, Carvana faces ongoing CFPB-style oversight, state licensing risk and any tightening of auto-lending standards.

Carvana is a genuinely improving business trading at a genuinely full price. The operating record is not in dispute - ten straight quarters of growth and profitability, revenue up 52% YoY in Q2 2026, $187M of free cash flow, equity rebuilt from $611M in Q3 2024 to $4.03B in Q2 2026, and raised EBITDA guidance of $2.7-3.0B. What has changed is that the market is no longer willing to pay for that growth at any multiple: the stock is down 14% in a month and sits below all three major moving averages, and the real warning sign is 240bps of gross-margin erosion over four quarters while revenue accelerated. My fair-value work lands near $70 versus $63.78 on 2026-10-04, which is modest upside rather than the 34% implied by the $85.23 consensus. Own it, do not chase it: wait for the 2026-10-28 print to show gross margin finding a floor and let the price reclaim the 50-day SMA (~$68.8) before sizing up.

Forward EV/EBITDA on a growth-adjusted multiple. I take the midpoint of 2026 Adjusted EBITDA guidance ($2.7-3.0B, so $2.85B), grow it 26% to ~$3.60B for FY2027 on continued 25-30% revenue growth, and apply 22x - a deliberate discount to the ~25x the stock trades at on 2026 EBITDA today, justified by the ~240bps of YoY gross-margin erosion and the fact that EBITDA growth (~25-30%) is now well below revenue growth (~50%). That yields a $79.2B enterprise value; subtracting net debt of $2.22B ($4.854B long-term debt less $2.63B cash as of 2026-06-30) gives ~$77.0B of equity, or ~$70/share on the 1.097B shares implied by the $69.96B market cap at $63.78. Cross-checks: at $70 the stock would trade ~2.7x FY2026E revenue of $28.92B and ~29x the analyst next-FY EPS of $1.616 - rich in absolute terms, but defensible for a market leader compounding EBITDA at 25%+.